Metraipolis › archive › dc_722797cde62c

LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41720851
DOI
10.1038/s41598-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-05T14:17:39.930Z
SHA-256 of the archived text
62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c
Stable URL of this page
https://metraipolis.com/documento/dc_722797cde62c

How to cite

LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851 — Europe PMC (en), https://europepmc.org/article/MED/41720851 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_722797cde62c (Metraipolis archive dc_722797cde62c, sha256 62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c)
BibTeX
@misc{dc722797cde62c,
  title = {LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41720851},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_722797cde62c; sha256 62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41720851. Agents can read the archived copy with the MCP tool read_document.